Javier, Chemie .
HRN: 16-76-48 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
11/11/2024
CEFUROXIME 500MG (TAB)
11/11/2024
11/18/2024
ORAL
500MG
BID X 7 Days
Post Partum Prophylaxis
Waiting Final Action
Indication: Empiric Type of Infection: Reproductive Tract Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes